New modalities in conformationally constrained peptides for potency, selectivity and cell permeation

Area of Science:

• Medicinal Chemistry
• Drug Discovery
• Biotechnology

Background:

• Peptide pharmaceuticals offer advantages in potency, selectivity, and reduced toxicity over small-molecule drugs.
• A key limitation of peptides is their poor stability in biological environments.
• Peptide modification through constraint is a strategy to enhance in vivo stability.

Purpose of the Study:

• To review recent advancements in peptide-constraining strategies.
• To highlight novel cyclization techniques for peptide drug development.
• To discuss the impact of these strategies on peptide therapeutic properties.

Main Methods:

• Review of recent scientific literature on peptide cyclization and modification.
• Analysis of novel chemical strategies for constraining peptide structures.
• Evaluation of studies demonstrating improved peptide properties post-constraint.

Main Results:

• Newer cyclization strategies have led to improved peptide stability against enzymatic degradation.
• Enhanced cell permeability and oral bioavailability have been observed with constrained peptides.
• Constrained peptides exhibit increased potency and selectivity at target receptors.

Conclusions:

• Peptide constraint is a viable approach to overcome stability limitations.
• Advancements in understanding peptide cell permeability and stability are crucial.
• Further development holds promise for increased clinical translation of peptide therapeutics for unmet medical needs.